Updated: June 4, 2024

Published: November 26, 2020

Shipping Live 3D In Vitro Spheroids Around the World with InFloat™ Shipping System

InSphero Head of Operations David Fluri explains how our new award-winning InFloat™ shipping system helps make 3D in vitro cell technology more accessible to researchers worldwide.

Did you know InSphero was the first biotech company to successfully ship live 3D spheroid models to labs worldwide in an assay-ready format? And we are still one of only a handful of companies able to do this. Shipping these delicate living microtissues while preserving their physiological function so that they are ready for compound dosing within hours upon receipt is not a trivial task. That’s why we have continued improving and refining different elements of our shipping technology over the past decade.

The Democratization of Advanced 3D Cell Cultures

In this blog post, I want to share with you how we deliver assay-ready microtissue models to our pharma and biotech partners internationally and what obstacles we had to overcome to make this a robust and accessible technology available for all.

InSphero assay-ready spheroid models, such as the 3D InSight™ Human Liver Microtissues, are complex, multicellular constructs assembled and matured using elaborate, highly standardized procedures to the point they leave our production facilities for their journey to our partners' labs. We ship these live, ready-to-use microtissues in scalable, automation-compatible, and technician-friendly Akura™ plate formats, engineered to make routine 3D cell culture maintenance and assay tasks easier and more efficient.

Packaging and shipping these live mini-organs from Switzerland to destinations in Europe, Asia, and North America poses unique challenges not only in terms of operational logistics but also in the way these delicate products must be protected during transport.

Microtissues are free-floating entities cultured and transported in multi-well plates engineered with special features that enable better visualization, maintenance, and analysis. The plates are sealed with a thermally glued membrane for transport, creating a closed compartment for each spheriod.

Single microtissues in the cell culture medium are located at the bottom of each well, where a cell-repellant surface prevents them from attaching to the plate. During shipment, the sealing foil secures the medium and microtissues in the wells but if the plates are tilted more than 90° for longer than a few minutes, the microtissues will eventually roll to the top of the wells, where they can get trapped and damaged.

InFloat™ shipping system: “Floating” microtissues from our bench to yours

We, therefore, started to develop a new packaging system to ensure plates always remained upright during transport. The idea behind the InFloat™ shipping system design was inspired by clever techniques devised by our ancestors, who added keels and counterweights to their dugout canoes to prevent capsizing.

Drawing from the same basic boat-building methods, we designed an inner sphere-shaped box holding the microtiter plates inside an outer box with a spherical void shape accommodating the sphere. Between the two parts, a layer of regular tap water allows the sphere to float and thereby move freely. The weight distribution of the inner packaging is designed so that regardless of the position of the outer box, the plates inside the floating sphere always remain upright – keeping the microtissues at the bottom of the well during the long journey from our production facility to your benchtop — ready to assay after a media exchange and brief recovery period in an incubator.

A picture showing Insphero's InFloat™ shipping system that consists of a spherical shipper floating on water inside of a rectangular outer container.

The InFloat™ shipping system consists of a spherical shipper floating on water inside a rectangular outer container.

Keeping it Simple

Keeping the plates upright is one part of the shipping challenge we had to overcome – preserving the structure and functionality of the complex mini-organs during multi-day transit times is another. Culturing microtissues typically requires high humidity, high CO2 levels, and robust thermal management. In a lab setting, this is achieved through sophisticated cell-culture incubators. Providing a similar environment in a transport system is possible, as such highly specialized shipping systems exist, but they are typically heavy, expensive, and often cannot be transported by regular express parcel services.

With the InFloat™ shipping system, we opted to go in another direction aiming to make our products more easily accessible and affordable to everyone keen on working with our 3D in vitro models and technology. To preserve microtissue health and function during transport, we decided to design the packaging system for shipping plates and media so as to avoid harmful extreme conditions, such as low temperatures or pH fluctuations in the media, but without overly complicating the transport system.

To minimize such extremes during shipment, we used lightweight materials with high thermal insulation coefficients combined with thermoelements made with phase-change materials.

These packaging elements, combined with transport media optimized for specific microtissue types, have proven to reliably safeguard the morphology and functionality of our live microtissues while in transit. Our spheroidal mini-organs proved to be astonishingly robust entities. We did extensive testing on these microtissue models and observed excellent stability of the spheroids for transit times up to 96 hours, exemplified here by morphology, viability, and functionality data of transport-simulated human liver microtissue cultures.

An image showing Insphero's liver microtissues after transportation with the InFloat™ shipping system

Biological stability of shipped microtissues with the InFloat™ shipping system exemplified by human liver co-cultures for 0h (incubator control), 48h, 72h, and 96h of shipment duration followed by a resting phase. A. Phase contrast micrographs and paraffine-embedded sections stained with H&E of human liver microtissues cultured in the incubator (control) or under shipment conditions for 96h. B. Tissue viability (ATP content). C. Tissue functionality (Albumin secretion).

The tissues endure shipping conditions for at least 96 hours without any measurable loss in viability or functionality. This time window allows us to safely transport our products to every laboratory in our primary markets in Europe, Japan, and the US. Typically, transit times to these destinations are substantially shorter than 96 hours, resulting in a comfortable safety margin in case of hold-ups in transit.

Being able to deliver truly assay-ready products of high quality internationally is key to making our complex 3D in vitro models available to a broad user base. We believe that putting this technology in the hands of as many researchers as possible worldwide ultimately contributes to discovering better and safer drugs.

InFloat™ Shipping System in the News

I hope you've found this blog post about InSphero's InFloat™ shipping system useful. If you'd like to learn more, I encourage you to read Keren Sookne's article in Healthcare Packaging, in which InSphero Vice President of Technology and Platforms, Dr. Olivier Frey, discusses the challenges of engineering a shipping system to keep fragile live tissues always upright — and how our design team took their inspiration from boat design.

InFloat™ Shipping System - How it Works

To see how we enable the safe transportation of live microtissues worldwide, watch this video of Olivier showing how to unpack the InFloat™ shipping system upon arrival.

Read More

antisense oligonucleotides
Blog

Understanding the DILI Risks of Antisense Oligonucleotides and the Value of Predictive In Vitro Testing

Antisense oligonucleotides (ASOs) offer therapeutic avenues for diseases that are currently unmet by alternative therapeutic modalities. However, the development of therapeutic ASOs is often hampered by hepatotoxicity. In this blog, we explore why 3D human liver microtissues are becoming an indispensable tool for de-risking ASO drug candidates and for reducing attrition in late-stage drug development. 

Read More »
Testing Drug-induced Mitochondrial Toxicity in 3D InSight™ Human Liver Microtissues
Blog

Testing Drug-induced Mitochondrial Toxicity in 3D InSight™ Human Liver Microtissues

Toxicological studies show that drugs can alter mitochondrial functions, potentially resulting in a deleterious range of toxic reactions from the induction of micro- and macrovesicular steatosis to lactic acidosis. These clinical manifestations are the consequence of drugs interfering with four main mitochondrial functions or constituents: aerobic respiration, beta-oxidation, and mitochondrial DNA homeostasis.

Read More »
Microplate technology
Blog

WHAT! Tissue Loss? InSphero Experts on Preventing Tissue Loss in Akura™ Spheroid Microplates

Ensuring that spheroids are intact during liquid exchange is not fun and certainly not easy. That’s why we developed our Akura™ Microplates with a special feature to make your life much easier: The SureXchange™ well design enables optimal protection of the spheroids in a cavity at the bottom of the well during liquid exchange.

What else do you need to know to prevent tissue loss? Our Senior Product Manager, Dr. Frauke Greve, asked InSphero's 3D in vitro experts about their tips and tricks.

Read More »
Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

View resource

Fill in the form below to view this resource